Results
Natco Pharma Q2 FY27 PAT at ₹2,026 Million
• Natco Pharma reported Q2 FY27 consolidated revenue of ₹10,194 Mn and a profit after tax of ₹2,026 Mn, including a ₹292 Mn share from its associate Adcock Ingram.
• The company acquired an additional
